Glycemic outcomes and patient satisfaction and self-management improves in transition from standard to virtual multidisciplinary care.

HbA1c Patient Reported Outcome Measures (PROMs) Telediabetes Telemedicine Time in Range (TIR) Type 1 Diabetes Mellitus (T1D)

Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
16 Feb 2024
Historique:
received: 30 12 2023
revised: 04 02 2024
accepted: 13 02 2024
medline: 19 2 2024
pubmed: 19 2 2024
entrez: 18 2 2024
Statut: aheadofprint

Résumé

With advances in cloud-based technologies, there has been a rise in remote T1D care. We hypothesized that transitioning T1DM care to a virtual, multidisciplinary clinic could improve measures beyond HbA1c. To assess the impact of transitioning from standard to virtual T1DM care, we evaluated glycemic measures and patient reported outcomes. Sixty-one adults with T1DM were included, with a mean age was 40.2 ± 13.5 years and diabetes duration 16.9 ± 9.0 years. Most patients were treated with insulin pumps and CGM. The number of annual diabetes care encounters rose from 2.1 ± 4.2 to 12.8 ± 5.5. Baseline HbA1c was 7.9 ± 1.6 %(63 ± 16.9 mmol/mol), declining to 7.3 ± 1.1 %(56 ± 8.5 mmol/mol) and 7.1 ± 1.0 %(54 ± 7.7 mmol/mol) at 6 and 12 months respectively (p < 0.001 for both). In parallel, TIR improved from 63.1 ± 19.3 % to 69.2 ± 13.8 % (p < 0.001) and 67.5 ± 19.4 % (p = 0.03) at 6 and 12 months respectively, while TBR declined. Scores from validated diabetes treatment and self-management questionnaires rose significantly and these rises were associated with a reduction in HbA1c, the latter score was also associated with increased TIR. There was a trend toward a correlation between encounter frequency and improvement in HbA1c and TIR. Transitioning from standard to virtual, coordinated, multidisciplinary T1DM care is associated with increased visit frequency, improving glycemic control, treatment satisfaction and self-care behaviors.

Identifiants

pubmed: 38368948
pii: S0168-8227(24)00070-6
doi: 10.1016/j.diabres.2024.111587
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111587

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Noga Minsky (N)

Division of Endocrinology, Diabetes, and Metabolism, Sheba Medical Center, Ramat Gan, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: noga.minsky@sheba.gov.il.

Liat Arnon Klug (L)

Division of Endocrinology, Diabetes, and Metabolism, Sheba Medical Center, Ramat Gan, Israel.

Tatyana Kolobov (T)

The Pesach Segal Israeli Center for Diabetes Research and Policy in Diabetes, Sheba Medical Center, Tel Hashomer, Israel.

Elizabeth Tarshish (E)

Department of Health Systems Management, Ariel University, Israel.

Yuval Shalev Many (Y)

The Pesach Segal Israeli Center for Diabetes Research and Policy in Diabetes, Sheba Medical Center, Tel Hashomer, Israel.

Aviva Lipsitz (A)

The Pesach Segal Israeli Center for Diabetes Research and Policy in Diabetes, Sheba Medical Center, Tel Hashomer, Israel.

Amna Jabarin (A)

Division of Endocrinology, Diabetes, and Metabolism, Sheba Medical Center, Ramat Gan, Israel.

Nicole Morozov (N)

Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Dania Halperin (D)

Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Division of Endocrinology and Diabetes, Hadassah Medical Center, Israel.

Moshe Shalom (M)

Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Rachel Nissanholtz-Gannot (R)

Department of Health Systems Management, Ariel University, Israel; Smokler Center for Health Policy Research, Myers-JDC-Brookdale Institute, Jerusalem, Israel.

Genya Aharon-Hananel (G)

Division of Endocrinology, Diabetes, and Metabolism, Sheba Medical Center, Ramat Gan, Israel.

Amir Tirosh (A)

Division of Endocrinology, Diabetes, and Metabolism, Sheba Medical Center, Ramat Gan, Israel; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Orly Tamir (O)

The Pesach Segal Israeli Center for Diabetes Research and Policy in Diabetes, Sheba Medical Center, Tel Hashomer, Israel.

Classifications MeSH